Tag: theraphy
Dual HER2 Blockade Improves Overall Survival With Metastatic Breast Cancer
NEW YORK (Reuters Health) Jul 09 – Dual HER2 blockade with trastuzumab and lapatinib extends overall survival in women with heavily pretreated HER2-positive metastatic breast cancer, researchers say. The findings from the phase III EGF104900 study were published online June 11 in the Journal of Clinical Oncology. A 2010 paper with preliminary data from the…
Read More